Your browser doesn't support javascript.
loading
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK.
Khoja, L; Nolan, K; Mekki, R; Milani, A; Mescallado, N; Ashcroft, L; Hasan, J; Edmondson, R; Winter-Roach, B; Kitchener, H C; Mould, T; Hutson, R; Hall, G; Clamp, A R; Perren, T; Ledermann, J; Jayson, G C.
Afiliación
  • Khoja L; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Nolan K; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Mekki R; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Milani A; UCL Hospitals NHS Foundation Trust and UCL Cancer Institute, London, UK.
  • Mescallado N; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Ashcroft L; Medical Statistics, Manchester Academic Health Sciences Clinical Trials Unit, Manchester, UK.
  • Hasan J; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Edmondson R; Department of Gynaecological Oncology and Institute of Cancer Sciences, St Marys Hospital and University of Manchester, Manchester, UK.
  • Winter-Roach B; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Kitchener HC; Department of Gynaecological Oncology and Institute of Cancer Sciences, St Marys Hospital and University of Manchester, Manchester, UK.
  • Mould T; UCL Hospitals NHS Foundation Trust and UCL Cancer Institute, London, UK.
  • Hutson R; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Hall G; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Clamp AR; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Perren T; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Ledermann J; UCL Hospitals NHS Foundation Trust and UCL Cancer Institute, London, UK.
  • Jayson GC; The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: Gordon.Jayson@christie.nhs.uk.
Clin Oncol (R Coll Radiol) ; 28(12): 760-765, 2016 12.
Article en En | MEDLINE | ID: mdl-27401967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido